ReviewGlobal cardiology science & practice2026
Incretin-based therapies and PPARγ agonists as regulators of adipokines-Nrf2 axis in diabetic cardiovascular disease.
Israa O Kashmoola et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.